Stories about Krankheit
- more
- 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
One documentmore - 2
Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
more Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
more- 3
Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access
more - 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
One documentmore
Gastrulation research reveals novel details about embryonic development
moreTechnische Universität München
Versatile, fast and reliable: new automated microarray rapid test detects SARS-CoV-2 antibodies
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36762/ High resolution images: https://mediatum.ub.tum.de/1615381 NEWS RELEASE Versatile, fast and reliable SARS-CoV-2 antibody assay Automated microarray ...
moreCoronavirus: Commission launches the Coronavirus Global R&I Collaboration Portal
Brussels (ots) - At the European Research and Innovation Days today, the European Commission launched a new coronavirus collaboration portal that offers matchmaking opportunities for researchers and research projects worldwide focusing on the socio-economic aspects of the coronavirus pandemic. The initiative supports the ’Global Approach to Research and ...
moreTechnische Universität München
Animal health through genomics | Feasibility study: Preventing diseases through genome analysis and genome scissors
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36757/ High resolution images: https://mediatum.ub.tum.de/1615373 Animal health through genomics Feasibility study: Preventing diseases ...
moreTechnische Universität München
In many cases, MS starts long before the diagnosis
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36707/ Picture: https://mediatum.ub.tum.de/1615270 NEWS RELEASE In many cases, MS starts long before the diagnosis Multiple sclerosis is often diagnosed years after the first symptoms appear Years before they ...
moreNOMOS Glashütte/SA Roland Schwertner KG
3Watches that help those who help
more
Sysmex Inostics presents data at ASCO
Baltimore, MD (ots) - Sysmex Inostics presents data at ASCO showing HPV-SEQ, a new CLIA-validated SafeSEQ NGS HPV16/18 liquid biopsy assay, is highly effective for measuring HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial. Sysmex Inostics, Inc., a global leader in the liquid biopsy revolution for oncology, is presenting the poster ...
moreDAAD Annual Report 2020: Lively exchange in difficult times
moreInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
moreDid my vaccine work? New rapid test for the determination of vaccination success
moreEANS-News: Covid-19 Crisis Continues to Massively Burden the Aviation Sector: Flughafen Wien Group Handles 88.7% Fewer Passengers, Revenue Decline of 64.4%
issuer: Flughafen Wien AG Postfach 1 A-1300 Wien-Flughafen phone: +43 1 7007 - 23126 FAX: +43 1 7007 - 23806 mail: investor-relations@viennaairport.com WWW: http://viennaairport.com/unternehmen/investor_relations ISIN: AT00000VIE62 indexes: stockmarkets: Wien language: ...
moreTechnische Universität München
Four ERC Advanced Grants for TUM scientists
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36588/ NEWS RELEASE EU funding for cutting-edge research Four ERC Advanced Grants for TUM scientists Artificial viruses made with DNA. The human lung as a computer model. A new approach to research on diseases ...
more
- 2
Lindis Biotech develops immunotherapy against bladder cancer
One documentmore Sysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients
Baltimore, MD, USA (ots) - Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster “Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer (NSCLC) patients” at the 112th Annual Meeting of the American Association for Cancer ...
moreIntroducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life
Berlin (ots) - The Novo Nordisk and Zur Rose Group collaboration presents DocMorris Adipositas Care, a digital hub which provides people living with obesity a new way to find the right care. Adipositas Care thoughtfully empowers people living with obesity by enabling them to learn about obesity and discover possible ...
moreSocial Stigma Burdens Innovative Lung Cancer-Therapies, Study Says
Social Stigma Burdens Innovative Lung Cancer-Therapies, Study Says Social stigma towards diseases such as lung cancer can hinder patients to seek treatment and, as a consequence, negatively affects the diffusion of innovative therapies, according to a recently published study. “Lung cancer carries a unique social stigma due to its association with cigarette smoking, and hence is often seen as a smoker’s disease, ...
moreFirst pocket inhaler for Covid-19 and other viral mutations
Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...
moreEANS-News: Flughafen Wien AG / Internationally recognised vaccination and test certificates as well as unified travel regulations are required to ensure responsible travelling once again
issuer: Flughafen Wien AG Postfach 1 A-1300 Wien-Flughafen phone: +43 1 7007 - 23126 FAX: +43 1 7007 - 23806 mail: investor-relations@viennaairport.com WWW: http://viennaairport.com/unternehmen/investor_relations ISIN: AT00000VIE62 indexes: stockmarkets: Wien language: ...
more
- 2
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
more Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins
One documentmoreEuropean Society for Medical Oncology (ESMO)
Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research
more- 2
BLOGPOST: Monthly motivation: How we deceive ourselves
more Information Office of Beijing Municipal Government
2Information Office of Beijing Municipal Government Releases "I am in Beijing for Spring Festival" Video Series
moreTechnische Universität München
New synthetic peptides could attenuate atherosclerosis
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36446/ NEWS RELEASE New synthetic peptides could attenuate atherosclerosis Synthetic “mini” receptors block atherosclerosis Atherosclerosis, a lipid-triggered chronic inflammatory disease of our arteries, is the main cause of strokes and ...
more